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STATEMENT OF JURISDICTION
The District

Court

of Utah County

entered

Summary

Judgment In Favor Of Searle Pharmaceuticals, Inc.; thereafter,
the Court entered a Certification For Appeal establishing the
Summary Judgment as a "final order".

From the Summary Judgment

and Certification, the plaintiff appeals to this Court in accordance with the provisions of Rule 54(a) and (b), Utah Rules of
Civil Procedure; and Rule 3(a), Rules of the Utah Supreme Court.

STATEMENT OF THE ISSUE
Whether the District Court correctly granted Summary
Judgment in Favor Of Searle Pharmaceuticals, Inc. in view of the
plaintiff's

failure to produce expert testimony to establish

that the Cu-7, intrauterine copper contraceptive, caused injury
to the plaintiff.

STATEMENT OF THE CASE
A.

NATURE OF THE CASE
This is a medical malpractice action against the de-

fendant, Doran V. Porter, M.D. ("Dr. Porter") arising out of his
alleged negligence in connection with the insertion of a Cu-7
intrauterine copper contraceptive into the uterus of the plaintiff and

the

subsequent

which developed.

pregnancy

and

related

complications

The plaintiff also asserts product liability

claims against Searle Pharmaceuticals, Inc. ("4Searle"), based

-1-

upon the contention that the Cu-7 is "defective and unreasonably
dangerous".

B.

COURSE OF PROCEEDINGS
After legal action had been initiated, discovery was

undertaken including the depositions of the plaintiffs and Dr.
Porter.

Thereafter, the Court held a Scheduling Conference at

which time dates were set for the designation of expert witnesses by plaintiff, the designation of expert witnesses by defendants, the completion of discovery, and trial.
failed

to designate

The plaintiff

the expert witnesses by the established

date; thereafter, Searle designated

its expert witnesses and

filed a Motion for Summary Judgment supported by the affidavit
of one of its expert witnesses.

Belatedly, plaintiff filed an

affidavit from one of her expert witnesses; however, the affidavit failed to indicate that the expert witness had reviewed
the medical records relating to the case and failed to address
the issue of whether the Cu-7 had caused any injury to plaintiff.

C.

DISPOSITION AT TRIAL COURT
Notwithstanding

the

fact

that

the

affidavit

from

plaintiff's expert witness was untimely filed, the Court considered the same and ruled that the plaintiff had "shown no expert
evidence or testimony to demonstrate a causal link between any

-2-

negligence on the part of defendant Searle and plaintiff's injuries" and that "summary judgment is appropriate".

D.

STATEMENT OF RELEVANT FACTS
1.

January 17, 1983—Dr. Porter inserted a Cu-7 into

the uterus of the plaintiff; the Cu-7 was manufactured and distributed by Searle.
2.
uterus.

(R. 1; R. 25.)

The plaintiff claims that the Cu-7 perforated her

Subsequent to the insertion of the Cu-7, plaintiff

became pregnant, and on May 13, 1983, aborted.
3.

(R. 1.)

August 8, 1985—Plaintiff initiated legal action

against Dr. Porter and Searle and asserted claims relating to
the Cu-7 based on strict products liability, negligence, breach
of express and implied warranties, and for punitive damages.
(R. 1.)
4.

May

8,

1987—The

District

Court

ordered

that

plaintiff designate expert witnesses by July 1, 1987 and that
defendants

designate

expert

witnesses

by

August

1,

1987.

(Scheduling Order; R. 177.)
5.

July 1, 1987 — Plaintiff failed to designate any

expert witnesses.
6.

(R. 181; R. 137.)

July 30, 1987—Searle

filed its Designation of

Expert Witnesses which included Howard G.McQuarrie, M.D.

Searle

also filed a Motion for Summary Judgment supported by the Affidavit of Howard G. McQuarrie, M.D.

-3-

(R. 202.)

7.

August

13, 1987—-Plaintiff

filed

a Motion for

Extension of Time in Which to Respond to Defendants' Motion for
Summary Judgment in which she sought a 30 day extension of time
to allow her "newly-retained experts" an opportunity to "document their opinions,"
8.

(R. 244; R. 266.)

August 27, 1987—The District Court made a "Rul-

ing" which granted plaintiff's Motion for Extension of Time as
to Dr. Porter, but denied the Motion as to Searle and granted
the Motion for Summary Judgment of Searle.

However, the Summary

Judgment In Favor Of Searle Pharmaceuticals, Inc. was not signed
by the Court at that time.
9.

(R. 310.)

September 8, 1 987 —Plaintiff filed her Designa-

tion of Expert Witness which included Charles W. March, M.D.,
and Robert E. Baier, PhD.
10.

(R. 315.)

September 15, 1987 — Plaintiff filed a Request for

Relief from Judgment pursuant to Utah Rules of Civil Procedure
60(b), and filed therewith the Affidavit of Robert E. Baier,
PhD.

(R. 368; R. 322.)
11.

January 27, 1988—After hearing oral arguments,

the Court ruled that the Affidavit of Robert E. Baier, PhD was
insufficient to create a prima facie case against Searle and the
Summary Judgment was signed and entered.

(R. 454.)

SUMMARY OF ARGUMENTS
The plaintiff's claims against Searle involve questions and issues that are not within the general knowledge and
-4-

understanding of lay persons and expert testimony was, therefore, necessary.
Plaintiff has failed to produce expert testimony to
support the claim that the Cu-7 was the cause of her injury.
Conversely,

Searle

produced

the

Affidavit

of

Howard

G.

McQuarrie, M.D., who expressed his opinion that the injury to
the plaintiff was not caused as a result of any defective and
unreasonably dangerous condition of the Cu-7 or as a result of
any negligence or other fault on the part of Searle.
Although plaintiff belatedly filed the Affidavit of
Robert E. Baier, PhD, this Affidavit was insufficient to create
a prima facie case against Searle, primarily for the reason that
it did not address the issue of causation.
The issue as to causation is uncontroverted in favor
of Searle, and the Summary Judgment was appropriately granted.

ARGUMENT
POINT I.
EXPERT TESTIMONY IS NECESSARY
TO ESTABLISH PLAINTIFF'S CLAIMS
Expert testimony is necessary where matters are at
issue that are not within the general knowledge and understanding of average citizens.
In Nixdorf v. Hicken, 612 P.2d 3^8 (Utah 1980), this
Court held:
In a majority of medical malpractice cases
the plaintiff must introduce expert testi-5-

mony to establish this standard of care.
Expert testimony is required because the
nature of the profession removes the particularities of its practice from the knowledge and understanding of the average citizen, (Emphasis added).
See also, Malmstrom v. Olsen, 400 P.2d 209 (Utah 1965); Kim v.
Anderson, 610 P.2d

1270 (Utah 1980); Jennings v. Stoker, 652

P.2d 912 (Utah 1982); and Farrow v. Health Servs. Corp., 604
P.2d 474 (Utah 1979).
The claims of plaintiff against Searle are medicallyrelated claims.

The questions and issues involved include whe-

ther the Cu-7 is an effective contraceptive, whether the Cu-7 is
defective and unreasonably dangerous, whether there was negligence in the design, testing, manufacturing, and/or marketing of
the Cu-7, whether appropriate warnings and instructions were
given by Searle as to the Cu-7, and whether the injury suffered
by plaintiff was caused by such claimed fault.

These are all

matters beyond the common understanding and knowledge of a lay
person and expert testimony was necessary and anticipated by all
parties.
The District Court ordered the plaintiff to identify
her experts by July 1, 1987.

Plaintiff failed to do so.

Searle timely identified

its experts and

filed the

Affidavit of Howard G. McQuarrie, M.D. in support of its Motion
for Summary Judgment.

In his Affidavit, Dr. McQuarrie states,

in relevant part, as follows:

-6-

3. I am familiar with the intrauterine
copper contraceptive known as the Cu-7,
manufactured and distributed by Searle Pharmaceuticals, Inc. (Searle).
I conducted
clinical research relating to the Cu-7 prior
to the approval of the same by the United
States Food and Drug Administration in 1974,
which approval continues to this date. I
have reviewed numerous medical articles,
publications, and reports relating to the
Cu-7 as well as other intrauterine contraceptive devices. I have also used the Cu-7
in connection with my clinical practice.
4. Based upon my education, training, experience, and upon review of the foregoing
documents, it is my professional opinion
that the Cu-7 is an effective contraceptive
and is not medically defective and unreasonably dangerous and that Searle exercised
appropriate judgment in connection with the
design, testing, manufacturing, and marketing of the Cu-7; further, the documents
provided with the Cu-7 by Searle gave adequate and appropriate instructions, warnings
and other information concerning the Cu-7 to
physicians and patients who utilized the
same .
5. It is further my professional opinion
that the complication which developed with
respect to the Cu-7 which was inserted into
the uterus of the plaintiff, Debra King, by
the defendant, Doran V. Porter, M.D., was
not caused as a result of any defective and
unreasonably dangerous condition of the Cu-7
or as a result of any negligence or other
fault on the part of Searle;...
(Affidavit of Howard G. McQuarrie, M.D. 1fs 3, 4, and 5; R. 205.)
Further, the testimony of Dr. Porter was also both
uncritical and, in fact, supportive of Searle and the Cu-7.

In

his deposition, Dr. Porter testified in relevant part, as follows :

-7-

Q: Now, the IUD that you were placing there
again was a Cu-7?
A: Yes.
Q:

Why did you choose that particular type?

A: Well, Ifve felt over the years that
they're more affective in contraception.

Q: Are
now?

you

recommending

them

[the

Cu-7]

Yes.
Are you still using them?
Yes.
Are you still placing them?
Yes.
Have the problems that Mrs. King experienced caused you concern about the recommendation of the Cu-7.
A: No, not necessarily. I don't think—not
with the function of the device.
(Deposition of Doran V. Porter, M.D. pp. 28-32; R. 510.)
The testimony

of Dr. McQuarrie

unchallenged and uncontroverted.

and Dr. Porter was

Plaintiff could not rely on

the mere allegations of her Complaint to controvert the expert
testimony.
This Court, in Freed Fin. Co. v. Stoker Motor Co., 537
P.2d 1039 (Utah 1975) held:
A party may not rely upon allegations in the
pleadings to counter affidavits made upon
personal knowledge stating facts contrary to
the allegations of the pleadings.
-8-

See also, Thornick v. Cook, 604 P.2d 934 (Utah 1979); and Celotex Corp, v. Cartrett, 106 S.Ct. 2548 (1986)
The District Court was correct in granting the Summary
Judgment.

POINT II.
THE AFFIDAVIT OF ROBERT E. BAIER,
PhD IS INSUFFICIENT TO ESTABLISH
A PRIMA FACIE CASE
A.
THE AFFIDAVIT IS NOT COMPETENT
Dr. Baier did not claim to have reviewed the relevant
medical records relating to this action which would be the minimum prerequisite to his being competent to offer testimony on
the issue of causation.
In Martin v. Mott, 744 P.2d 337 (Utah App. 1987), the
Court affirmed summary judgment in favor of a defendant in a
medical malpractice case due to the fact that the plaintiff
failed to present competent expert testimony in support of her
claim.

The Court pointed out that the expert testimony proffer-

ed by the plaintiff was not competent to support the claim in
that the expert was not familiar with the facts of the case.
The Court stated:
...Also, Dr. Fleming [plaintiff's expert]
was, by his own admission, not familiar with
any facts surrounding plaintiff's treatment.
As stated in Edwards v. Didericksen, 597
P.2d 1328 (Utah 1979).
"The admissibility
of [expert] evidence depends in large mea-9-

sure upon the foundation laid. The expertise of the witness, his degree of familiarity with the necessary facts, and the
logical nexus between his opinion and the
facts adduced must be established." (Emphasis in original).

B.
THE AFFIDAVIT WAS UNTIMELY
This Court has previously held that summary judgment
is appropriate due to a party's failure to comply with discovery
deadlines and that any request for an extension of time must be
made before the date of the discovery deadline.

W.W. & W.B.

Gardner, Inc. v. Park West Village, Inc., 568 P.2d 73^ (Utah
1977).

In this case, plaintiff failed to designate an expert

within the allowable time set by the Court, nor did plaintiff
request additional time to obtain an expert prior to the Court's
deadline.

C.
THE AFFIDAVIT DOES NOT ADDRESS
THE ISSUE OF CAUSATION
Notwithstanding

the deficiency in the factual basis

supporting the Affidavit of Robert E. Baier, PhD and the untimely filing of the same, as outlined above, the District Court
considered

the Affidavit which contains the following general

statement:
3. It is my opinion that the copper contained in the Cu-7 intrauterine device has
-10-

an almost identical effect upon the tissues
of the human female and this effect permits
the device to perforate the uterus and migrate to other parts of the body.
4. In my opinion, the Cu-7 is an inherently
dangerous device inappropriate for implantation in the female uterus.
(Affidavit of Robert E. Baier, PhD 1[s 3 and 4; R. 370.)
Significantly, the Affidavit is completely silent as to causation.
A substantially identical issue was recently raised in
Hoopiiaina v. Intermountain Health Care, 740 P.2d 270 (Utah App.
1987).

In that case, the plaintiff asserted a medical malprac-

tice claim against LDS Hospital due to the fact that she was
given a drug which had been ordered for another patient.

The

Hospital admitted that it had been negligent in administering
the drug

to the plaintiff, but denied

plaintiff any injury.
Judgment

based

upon

that the drug caused

The Hospital filed a Motion for Summary
this contention, which was supported by

appropriate affidavits from experts.

The Motion was granted

because, as here, the plaintiff failed to produce any expert
testimony to establish causation, i.e., that he had been damaged
by the Hospital's negligence.

The Court stated in relevant part

as follows:
In medical malpractice actions, the plaintiff must provide expert testimony to establish:
1) The standard of care, Marsh y.
Pemberton, 10 Utah 2d 40, 347 P. 2d 1108,
1110 (T959); 2) defendant's failure to
comply with that standard, Nixdorf v.
Hicken, 612 P.2d 348, 351 (Utah 1980); and,
-11-

3) that defendant caused plaintiff's injuries, Huggins v. Hicken, 6 Utah 2d 233, 310
P.2d T23i 52^ (1957).
Further, issues of
fact which are outside the knowledge and
experience of lay persons must be established by expert testimony.
Kim v. Anderson,
610 P.2d 1270, 1271 (Utah 1980) .

...In the absence of an expert to testify
for plaintiff that the quinidine harmed him,
the court correctly concluded that the jury
would have no evidence upon which to base a
finding that the quinidine caused any harm
to plaintiff.... Thus, no genuine disputes
of material fact existed to preclude granting the motion for summary judgment.
Further,

in

the

recent

decision

of

Chadwick

v.

Nielson, 94 U.A.R. 45 (Utah App. 1988), the Court held:
The medical malpractice plaintiff must still
ordinarily provide expert testimony...to
establish that the doctor's negligence proximately caused plaintiff's injury [citations
omitted]. In other words, while it may be
common knowledge that a reasonable medical
practitioner would not leave a needle in a
patient's body, it requires expert testimony
to establish that the lost needle is causing, for example, plaintiff's headaches.
(Emphasis added).
Although plaintiff belatedly produced expert testimony
supporting her claim that the Cu-7 is "inherently dangerous",
thus arguably creating a question of fact as to that issue,
plaintiff failed to produce any evidence to establish that the
Cu-7 caused her injury.

The District Court correctly ruled that

this deficiency was fatal and that plaintiff's claim must therefore fail.
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D.
THE INVOCATION OF RES IPSA LOQUITUR
DOES NOT RELIEVE PLAINTIFF FROM
PROVING CAUSATION
Plaintiff also relies for the first time on appeal on
the doctrine of res ipsa loquitur in her claim that the Summary
Judgment was inappropriate.

However, plaintiff is in error in

her claim that the mere invocation of the doctrine relieves a
plaintiff of the burden of proving causation.
In Robinson v. Intermountain Health Care, 740 P.2d 262
(Utah App. 1987), the Court held:
The mere invocation of the doctrine [res
ipsa loquitur], however, does not result in
its automatic application. In order to rely
on res ipsa loquitur, a plaintiff must first
establish a sufficient evidentiary foundation to support application of the doctrine
and its inference of negligence.

...Commenting on the plaintifffs dilemma in
making this preliminary foundational showing
in a medical malpractice action, the Utah
Supreme Court has noted:
Generally, this requires the introduction of expert medical testimony to
establish the fact that the outcome is
more likely the result of negligence
than some other cause. This testimony
would be necessary to provide the
evidentiary basis from which the jury
could conclude the result is more
probably than not due to the negligence of the attending physician.

In order to create a genuine factual dispute
on this point, Robinson thus had to come
-13-

forward with evidence to counter Dr. Burke's
affidavit
opinion—that
non-negligence
causes of her infection were probable—with
expert
testimony
to
the
effect
that
Robinson's infection most likely resulted
from negligence, assuming it was possible to
find an expert who could and would make such
a statement....
See also, Talbot v. Groves Latter-Day Saints Hosp., 21 Utah 2d
73, 440 P.2d 872 (1968), wherein this Court held:
In examining the facts of the case before
us, we are of the opinion that there is
insufficient foundation on which to base the
doctrine of res ipsa loquitur.
The fact
plaintiff's disability resulted from an
uncommon or rare occurrence does not release
him from the burden of establishing causation . An inference of negligence cannot be
permitted solely upon the basis that the
plaintiff developed a rare complication
while undergoing medical and surgical treatment. The doctrine of res ipsa loquitur has
no application unless it can be shown from
past experience that the occurrence causing
the disability is more likely to result from
negligence than some other cause.... (Emphasis added).
Invoking the doctrine of res ipsa loquitur does not
waive the requirement of producing expert testimony as to causation, and the plaintiff has produced none.
Further, the plaintiff raises this issue for the first
time on appeal.

This Court has consistently held that an issue

raised for the first time on appeal cannot be considered and
should so hold in this case.

See, e.g. Lane v. Messer, 731 P.2d

488 (Utah 1986); Bundy v. Century Equip. Co., 692 P.2d 754 (Utah
1984); and Combe v. Warren's Family Drive-ins, Inc., 680 P.2d
733 (Utah 1984).
-14-

E.
PLAINTIFF'S OTHER EXPERT IS
NOT CRITICAL OF THE THE Cu-7
It should also be noted that plaintifffs other expert,
Charles W. March, M.D., whose deposition was taken after the
District Court granted the Summary Judgment is not critical of
the Cu-7-

Dr. March testified in relevant part as follows:
Q: I get the impression that you do not
quarrel with the decision to use a Copper 7?
A:

No.

Q: And you think the choice of device was
proper?
A: I would probably have used a plastic
device in a woman, if I remember, who had
three children.
But, again, absolutely
nothing wrong with the Copper 7.

Q: And the choice of Copper 7 was within
the standard of care?
A:

Correct.

Q: ...As of January f 83, it was your opinion that the Copper 7 was a safe device, is
that right, relatively safe device?
A: And that there was no conclusive evidence to the contrary.
Q: And have you learned anything since then
that would change your mind?
A:

No.

(Charles W. March, M.D. depo., pp. 13, 14, 21 and 29).
-15-

The fact that plaintiff's expert, who had reviewed the
relevant medical records, has no quarrel with Searle's position
and the use of the Cu-7, further strengthens the conclusion that
Summary Judgment was appropriate.

CONCLUSION
Plaintiff has failed to produce any evidence that the
injury she sustained was caused by claimed "defective and unreasonably dangerous" conditions of the Cu-7, and her claim against
Searle cannot be maintained.

The Summary Judgment should be

affirmed.
DATED this 15th day of December, 1988.
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ADDENDUM "A"

J. ANTHONY EYRE (#1022)
KIPP AND CHRISTIAN, P.C.
Attorney for Defendant
Searle Pharmaceuticals Inc.
City Centre I, #330
175 East Fourth South
Salt Lake City, Utah 84111
Telephone: (801) 521-3773
IN THE FOURTH JUDICIAL DISTRICT COURT OF UTAH COUNTY
STATE OF UTAH
DEBRA KING and CURTIS KING,
Plaintiffs,

:
:

AFFIDAVIT OF
HOWARD G. McQUARRIE, M.D.

vs.
DORAN V. PORTER, M.D. and
SEARLE PHARMACEUTICALS INC.
a foreign corporation,
Defendants.
STATE OF UTAH

:
:

Civil No. 70,361

:
)
) ss.
)

County of Salt Lake

Howard G. McQuarrie, M.D., being first duly sworn,
deposes and says:
1.

I am a physician licensed to practice medicine

in the State of Utah and have a speciality in the field
of

Obstetrics

Vitae

setting

and

Gynecology.

forth

in

general

A

copy
my

of my Curriculum

education,

training,

qualifications and experience is attached as Exhibit "A".

2.

I have reviewed the following documents re-

lating to this case:
a.

Medical records:
Richard W. Lohner, M.D. and Kent R.
Gammett, M.D.
Samuel J. Hammond, M.D.
Doran V. Porter, M.D.
Utah Valley Hospital —

12/1/79 - 12/4/79

Orem Community Hospital ~ 8/22/82
Orem Community Hospital ~

11/25/82 - 11/30/82

Utah Valley Hospital — 4/19/83
Orem Community Hospital — 4/21/83
Provo Surgical Center —

5/13/83

b. Depositions:
Doran V. Porter, M.D. —

2/12/86

Debra King ~ 4/09/86
Curtis King — 4/09/86
c.

Searle Pharmaceuticals
panying the Cu-7:

Inc. documents accom-

Physician Insert
Exhibit "B")

4/08/82

—

"For The Patient" Brochure —
as Exhibit "C")
3.

(Attached

as

4/12/82 (Attached

I am familiar with the Intrauterine Copper

Contraceptive known as the Cu-7 manufactured and distributed

-2-

by

Searle

Pharmaceuticals

Inc.

(Searle).

I

conducted

clinical research relating to the Cu-7 prior to the approval
of the same by the United States Food and Drug Administration
in 1974 which

approval

continues to this date.

I have

reviewed numerous medical articles, publications and reports
relating to the Cu-7 as well as other intrauterine contraceptive

devices.

I have

also used

the Cu-7 in connection

with my clinical practice.
4.
and upon

Based upon my education, training, experience

a review of the foregoing documents, it is my

professional

opinion

that

the

Cu-7

is

an

effective

contraceptive and is not medically defective and unreasonably
dangerous, and that Searle exercised appropriate judgment
in connection with the design, testing, manufacturing and
marketing

of

with

Cu-7

the

instructions,

the
by

Cu-7;

further,

Searle

warnings

and

gave

the

documents

adequate

other

and

information

provided

appropriate
concerning

the Cu-7 to physicians and patients who utilized the same.
5.

It is further my professional opinion that

the complication which developed with respect to the Cu-7
which was inserted into the uterus of the plaintiff, Debra
King, by the defendant Doran V. Porter, M.D. was not caused
as a result of any defective and unreasonably
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dangerous

condition

of the Cu-7 or as a result of any negligence

or other fault on the part of Searle; perforation of the
uterus by the Cu-7 at the time of insertion can occur in
the

absence

of

negligence

or fault

on the part

of the

treating physician or any other party.
DATED this

£Cf

day of July, 1987.

HOWARD G. McQUARRIE, M.D.
SUBSCRIBED AND SWORN to before me this

cS 7 7 ^

day of July, 1987.

NOTARYjPUBLIC, residing at
My Commission Expires:

L

/••2-/^-?y
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ADDENDUM "B"

WAYNE B. WATSON, P.C. - 3405
TERRI C. BINGHAM - 454 0
WATSON, SEILER & OREHOSKI
Attorneys for Plaintiff
2696 N. University Ave., Suite 220
Provo, UT 84604
Telephone: (801) 375-5600
IN THE FOURTH JUDICIAL DISTRICT COURT OF UTAH COUNTY
STATE OF UTAH
DEBRA KING, et al..
Plaintiff,

AFFIDAVIT OF ROBERT E.
BAIER, Ph.D.

vs.
DORAN V. PORTER, M.D., et
al. ,

Civil No. 70361
(Judge Cullen Y. Christensen)

Defendants.
STATE OF NEW YORK )
:ss.
COUNTY OF ERIE
)
ROBERT E. BAIER, being first duly sworn upon his oath,
states as follows:
1.

I am the director of the Health-Care Instruments and

Devices Institute located at the State University of New York at
Buffalo.

A biographical sketch, which outlines my qualifications

to render the opinions which follow, is attached as Exhibit "A".
2.

I have participated in e-1 ir.ioal studies to determine

the effect of pure metallic copper upon animal tissues. Specifically, I have observed the effect of copper, implanted beneath

the skin of New Zealand white rabbits.

The copper caused tissue

destruction of such gross magnitude that within 20 days the implant
perforated the animal's skin and dropped to the floor of its cage.
3.

It is my opinion that the copper contained in the CU-7

intrauterine device has an almost identical effect upon the
tissues of the human female, and this effect permits the device
to perforate the uterus and migrate to other parts of the body.
4.

In my opinion the CU-7 is an inherently dangerous

device inappropriate for implantation in the female uterus.
DATED this j ^ day of September, 1987.
V _

>

ROBERT E. BAIER, Ph.D.
SUBSCRIBED and SWORN to before me this
ber, 1987.

NOTARY PUBLIC
My Commission Expires:
Residing at:

2

- -^-day of Septem-
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DirectoT TleaTtlv^care- " BWTHOATE fMa.. Off. »J
Instruments 4 Devices I n s t i t
October 31, 1939
(HIDI) SUNYAB
TITLE

AME

Robert E. Baier
DUCATOH f3*yr w» t+zctHs+tt
HSmVTrOH

a c&v hZ* prsksvoni/t&esOoti tnd Mvd* pc&Zxty*

ANO LOCATION

rieveland State U n i v e r s i t y , Cleveland, OH
State University of New York at Buffalo, NY
iatiotval Academy of Sciences-National
Research Council, Washington, D.C.
ZSEtfXX

^OTK*^.

DEGREE

Ph.D.
Postdoc,

trvntig)
YEAR
CONFERRED

1962
1966
1966-1968

FIELD 0? STUDY

Physics
Biophysics
Surface Chemistry

AND THAWING SUPPORT (S** nstnKtarm)

Responsible for the d i r e c t i o n and performance of i n t e r d i s c i p l i n a r y studies in surface
and environmental chemistry for the past two decades.
>rincipal I n v e s t i g a t o r on over $3,000,000 of funded research* and c o - i n v e s t i g a t o r on
over $10,000,000 of additional funded research, since 1966.
iajor sponsoring agencies have been Rational I n s t i t u t e s of Health, U.S. Department of
the Array, U.S. Department o f the Navy, U.S. Environmental Protection Agency, 0. S.
Department of Energy, and a large variety of commercial firms involved in the
development of biomedical devices.
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kcademic A p p o i n t m e n t s :
F a c u l t y A s s o c i a t e i n t h e U n i v e r s i t y Seminar on B i o m a t e r i a l s ,

Columbia University in the City of New York, 1970-present
National Advisory Board, Biomedical Engineering Program, Clemson
University, Clemson, South Carolina, 1970-1982
Consultant in Biomaterials, Department of Experimental Pathology,
Roswell Park Memorial Institute, 1970-present
Adjunct Associate Professor, School of Chemical Engineering,
Cornell University, Ithaca, New York, 1971-1976
Assistant Research Professor, Department of Biophysics, Rosvell
Park Memorial Institute Graduate School of the State University
of Sew York at Buffalo, 1972-present
Sonors and Awards:

Clemson Award for Basic Research, awarded by Society of
Biomaterials, 1983

Professional Appointments:

Selected Publications:

Editorial Board, Journal of Biomedical Materials Research,
1977-present
International Advisory Board, Journal of Bioengineering,
1978-1980
Working Group on Physicochemical Characterisation of
Biomaterials, National Heart, Lung, and Blood Institute,
National Institutes of Health, leading to publication of
"Guidelines for Physico-Chemical Characterization of
Biomaterials", NIH Publication No. 80-2186, September 1980,
1978-1980

9 of a total of 200

Baier, R. JL-» N a t i e l l a , J. R., Meyer, A. E., Carter, J. M., Fomalik, M. S . , and
Turnbull, T., "Surface Phenomena in In Vivo Environemts", In Materials Sciences and
Implant Orthopedic Surgery, (Editors, Ram Kossowsky and Nir Kossovsky), Martinus
Nijhoff P u b l i s h e r s , Boston, pp 153-188, 1986

ADDENDUM "C"

DISTRICT COURT OF UTAH COUNTY,
STATE OF UTAH

DEBRA KING,
Plaintiff,

Case No. 70361

vs.

RULING

DORAN V. PORTER, M.D., et al.,
Defendants.

This matter comes before the Court, under Rule 2.8,
on the motion of plaintiff seeking relief from the Court's
Ruling of August 28, 1987 granting a Summary Judgment in
favor of defendant Searle Pharmaceutical.

The Court has

reviewed the file, considered the memoranda of counsel,
entertained nrsuiaent; of counsel, and upon being advised
in the premises, now makes the following:
RULING
1.

Said motion is denied on the following bases: ^
(a)

Even though plaintiff has now designated

her purported expert witness as heretofore ordered by the
Court and has responded to defendant Searle!s Motion for
Summary Judgment, such response, which has been fully considered
by the Court, is, in the opinion of the Court, insufficient
to forestall Summary Judgment.
In Hoopiiaina v. IHC, 740 P.2d 270, the Utah
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Court of Appeals held that:
"In medical malpractice actions the plaintiff must
provide expert testimony to establish: 1) the standard
of care, Marsh v. Pemberton, 10 Utah 2.d 40, 347 P.2d
1108, 1110 (1959); 2) defendant's failure to comply with
that standard, Nixdorf v. Hicken, 612 P.2d 348, 351 (Utah
1980); and 3) that defendant caused plaintiff's injuries.
Huggins v. Hicken, 6 Utah 2d 233, 310 P.2d 523, 526 (1957).
Further issues of fact which are outside the knowledge
and experience of lay persons must be established by expert
tesitmony. Kim v. Anderson, 610 P.2d 1270, 1271 (Utah
1980).
Defendant Searle in support of its Motion Summary
Judgment submitted the Affidavit of Dr. Howard G. McQuarrie,
M.D. as an expert who, after reviewing all of the relevant
medical records and other documents pertaining to plaintiff's
claims, affirmed as follows:
"3. I am familiar with the intrauterine copper contraceptive known as the CU-7, manufactured and distributed
by Searle Pharmaceuticals, Inc. (Searle). I conducted
clinical research relating to the CU-7 prior to the approval
of the same by the United States Food and Drug Administration in 1974, which approval continues to this date.
I have reviewed numerous medical articles, publications
and reports relating to the CU-7 as well as other intrauterine contraceptive devices. I have also used the CU-7
in connection with my clinical practice.
fl

4. Based upon my education, training, experience,
and upon review of the foregoing documents, it is my
professional opinion that the CU-7 is an effective contraceptive and is not medically defective and unreasonably
dangerous and that Searle exercised appropriate judgment
in connection with the design, testing, manufacturing, and
marketing of the CU-7; further, the documents provided with
the CU-7 by Searle gave adequate and appropriate instructions,
warnings, and other information concerning the CU-7 to
physicians and patients who utilized the same.
"5. It is further my professional opinion that the
complication which developed with respect to the CU-7 which
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developed with respect to the CU-7 which was inserted into
the uterus of the plaintiff, Debra King by the defendant
Doran V. Porter, M.D., was not caused as a result of any
defective and unreasonably dangerous condition of the CU-7
or as a result of any negligence or other fault on the
part of Searle; . . ."
Plaintiff in a response to said Affidavit has
filed an Affidavit by Robert E. Baier, Ph.D, as an expert,
who did not purport to have examined any of the medical
records in this case and whose experiments with respect to
the CU-7 were conducted on rabbits, who affirmed as follows:
"3. It is my opinion that the copper contained in the
CU-7 intrauterine device has an almost identical effect
upon the tissues of the human female, and this effect permits
the device to perforate the uterus and migrate to other
parts of the body.
I!

4. In my opinion the CU-7 is an inherently dangerous
device inappropriate for implantation in the female uterus/1
Even assuming for the sake of argument that the
Baier Affidavit raises a genuine issue of fact as to plaintiff's
claim that the CU-7 is "inherently dangerous," an assumption
which the case of Martin v. Mott, 68 Ut. Adv. Rep. 33,
would belie because of the unfamiliarity of Baier with the
records in the case, such affidavit does not, nor has
plaintiff through any other means attempted to establish
through credible evidence that the CU-7 caused any injury
or damage to the plaintiff.

Plaintiff has thus failed to

make out a prima facie case against defendant Searle.
In Hoopiiaina, supra, the Court of Appeals noted
that expert testimony was necessary to establish the fact
that the conduct of the defendant caused plaintiff harm
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and stated:
"In the absence of an expert to testify for plaintiff
that the quinidine harmed him, the court correctly concluded
that the jury would have no evidence upon which to base
a finding that the quinidine caused any harm to plaintiff.
. . • Thus, no genuine disputes of material fact existed
to preclude granting the motion for summary judgment."
Plaintiff asserted in oral argument that in any event the
doctrine of res ipsa loquitur is prima facie applicable so
as to preclude summary judgment.

That doctrine may in

unusual circumstances be permitted to carry the burden of
establishing a duty of reasonable care owed by the defendant
to the plaintiff and a breach of that duty.

It is an

evidentiary doctrine aiding in the proof of negligence;
it has no bearing on the issue of causation, which must be
separately and independently established.

This was so held

in Robinson v. IHC, 62 Ut. Adv. Rep. 21. The Robinson
Court further quoted from Anderton v. Montgomery, 607 P.2d
828 as follows:
"As in any negligence action, a legally-recognizable
causal link must be established between defendant's act or
omission and plaintifffs injury. Absent such a causal
relationship, defendant's conduct, negligent or otherwise,
gives rise to no liability. Res Ipsa loquitur does not
relieve plaintiff of this obligation; rather, it permits
him, in lieu of linking his injury to a specific act on
defendant's part, to causally connect it with an agency or
instrumentality, under the exclusive control of the defendant, functioning in a manner which, under the circumstances,
would produce no injury absent negligence. However, where
the agency or instrumentality is not established to be the
cause of plaintiff's injury, or where it is not shown to be
under the exclusive control of the defendant, the causal
connection is not established, and the inference of negligent
conduct giving rise thereto is nullified."
This Court is of the opinion that plaintiff has
shown no expert evidence or testimony to demonstrate a causal
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link between any negligence on the part of defendant Searle
and plaintiff's injuries.

Thus summary judgment is appro-

priate.
For the reasons hereinabove stated Summary Judgment
against plaintiff and in favor of defendant Searle is
confirmed and granted.

The proposed judgment heretofore

submitted by counsel for said defendant has been signed
this date.
The proposed Order denying plaintiff's motion for
relief from judgment or Order heretofore submitted by counsel
for said defendant has likewise been signed this date.
The proposed Order denying plaintiff's Motion for
Extension of Time in which to Answer Defendant's Motion for
Summary Judgment as to Searle Pharmaceutical heretofore
submitted by counsel for said defendant is refused and is
returned to counsel herewith unsigned.
Dated this

y7~

day of January 1988.

BY THE COURT:

IN THE FOURTH JUDICIAL DISTRICT COURT
UTAH COUNTY, STATE OF UTAH

DEBRA KING, et al.,
Plaintiffs,

CASE NUMBER:

70,361

vs.

DATE:

JANUARY 27, 1988

DORAN V. PORTER, et al.,

CULLEN Y. CHRISTENSEN, JUDGE

Defendants.
PROOF OF MAILING

I, Sandra Starley, being first duly sworn according to
law, upon oath, depose and say: that I am a citizen of the
United States of America, over the age of twenty-one years; that
on the 27th day of January, 1986, I deposited in the United
States Post Office at Provo, Utah, enclosed in sealed envelopes
with first-class postage fully prepaid theron, true copies of
said ruling to the following to-wit:
Wayne B. Watson
Terri C. Bingham
WATSON, SEILER & OREHOSKI
2696 N. University Ave, Suite 220
Provo, Utah 84604
J. Anthony Eyre
KIPP & CHRISTIAN, P.C.
175 East 400 South, Suite 330
Salt Lake City, Utah 84111
David W. Slagle
SNOW, CHRISTENSEN & MARTINEAU
P.O. Box 45000
Salt Lake City, Utah 84145
Dated this 27th day of January, 1988

i > J-hf

ADDENDUM "D"

J. ANTHONY EYRE (#1022)
KIPP AND CHRISTIAN, P.C.
Attorney for Defendant
Searle Pharmaceuticals Inc.
City Centre I, #330
175 East Fourth South
Salt Lake City, Utah 84111
Telephone: (801) 521-3773
IN THE FOURTH JUDICIAL DISTRICT COURT OF UTAH COUNTY
STATE OF UTAH
DEBRA KING and CURTIS KING,
Plaintiffs,

:
:

vs.

SUMMARY JUDGMENT IN
FAVOR OF
: SEARLE PHARMACEUTICALS INC.

DORAN V. PORTER, M.D. and
SEARLE PHARMACEUTICALS INC.,
a foreign corporation,

:

Defendants.
The

Motion

Civil No. 70,361

:
For

Summary

Judgment

of

Searle

Pharmaceuticals Inc. having been considered by the Court,
including the Memorandum of Authorities in support of the
Motion; the Court being fully advised in the premises and
having

heretofore

entered

in writing

its Ruling

on the

Motion, now enters the following Order:
1.

The

Motion For Summary

Pharmaceuticals Inc. is granted.

Judgment

of Searle

against

2o

an d Q /7i&*, J* <J Covtp la /# b
The Complaint/7 of the plaintiff Debra King

the

defendant

Searle

Pharmaceuticals

Inc. is

dismissed with prejudice.
DATED this

2 /

day of §04=&£5^, 19SS&
BY THE COURT:

(Sullen Y . ^ a r i s t e n s e n
D i s t r i c t Court Judge
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CERTIFICATE OF MAILING
MAILED,

postage

prepaid,

this

r^K

day

of

August,

1987, a true and correct copy of the foregoing

Summary

Judgment

In Favor Of Searle Pharmaceuticals, to

the following:
Wayne B. Watson
Terri C. Bingham
WATSON, SEILER & OREHOSKI
Attorneys for Plaintiffs
2696 North University Avenue
Suite 220
Provo, Utah 84604
David W. Slagle
SNOW, CHRISTENSEN & MARTINEAU
Attorneys for Defendant Porter
P. 0. Box 45000
Salt Lake City, Utah 84145

)Jkdk\ Tgpftfa
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